Publication | Closed Access

Efficacy and Safety of OPANA ER (Oxymorphone Extended Release) for Relief of Moderate to Severe Chronic Low Back Pain in Opioid-Experienced Patients: A 12-Week, Randomized, Double-blind, Placebo-controlled Study

Pain TherapyPain ResearchHealth SciencesOxymorphone Extended ReleasePain MedicineOpioid-experienced PatientsOpana ErBack PainPain ManagementRehabilitationMedicineAnalgesicsOpioid Use DisorderAnesthesiologyPain Treatment